Total Payments
$75,178
2024 Payments
$25,576
Companies
13
Transactions
290
Medicare Patients
517
Medicare Billing
$94,882
Payment Breakdown by Category
Other$59,422 (79.0%)
Consulting$5,273 (7.0%)
Travel$5,261 (7.0%)
Food & Beverage$5,203 (6.9%)
Education$19.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,422 | 24 | 79.0% |
| Consulting Fee | $5,273 | 2 | 7.0% |
| Travel and Lodging | $5,261 | 23 | 7.0% |
| Food and Beverage | $5,203 | 239 | 6.9% |
| Education | $19.24 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $73,825 | 199 | $0 (2024) |
| Currax Pharmaceuticals LLC | $378.34 | 30 | $0 (2024) |
| Abbott Laboratories | $218.99 | 13 | $0 (2024) |
| Lilly USA, LLC | $199.70 | 12 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $128.86 | 8 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $105.01 | 9 | $0 (2020) |
| Rhythm Pharmaceuticals, Inc. | $93.42 | 5 | $0 (2024) |
| Intra-Sana Laboratories | $85.20 | 3 | $0 (2023) |
| EISAI INC. | $48.28 | 4 | $0 (2019) |
| Nalpropion Pharmaceuticals LLC | $37.06 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,576 | 43 | Novo Nordisk Inc ($25,334) |
| 2023 | $13,446 | 52 | Novo Nordisk Inc ($13,060) |
| 2022 | $34,621 | 80 | Novo Nordisk Inc ($34,407) |
| 2021 | $359.80 | 27 | Novo Nordisk Inc ($274.87) |
| 2020 | $332.43 | 20 | Novo Nordisk Inc ($238.49) |
| 2019 | $270.17 | 27 | Novo Nordisk Inc ($210.22) |
| 2018 | $297.43 | 28 | Novo Nordisk Inc ($127.34) |
| 2017 | $275.33 | 13 | Novo Nordisk Inc ($174.30) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,607.50 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $1,047.16 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,405.00 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,867.50 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $58.97 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $52.26 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $157.50 | General |
| Category: Obesity | ||||||
| 06/17/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,360.00 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $307.12 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $271.42 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $196.24 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $184.25 | General |
| Category: Obesity | ||||||
| 05/20/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Obesity | ||||||
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.37 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 155 | 393 | $77,923 | $25,564 |
| 2022 | 4 | 119 | 501 | $61,080 | $29,037 |
| 2021 | 8 | 179 | 516 | $51,285 | $31,029 |
| 2020 | 3 | 64 | 128 | $18,310 | $9,253 |
Total Patients
517
Total Services
1,538
Medicare Billing
$94,882
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 195 | $43,752 | $14,387 | 32.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 80 | $11,432 | $3,533 | 30.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 83 | $10,235 | $3,445 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $8,628 | $2,960 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,877 | $1,239 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 206 | $31,116 | $14,992 | 48.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 18 | 153 | $13,056 | $6,480 | 49.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 16 | 121 | $12,847 | $5,917 | 46.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,061 | $1,649 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 150 | $18,750 | $11,265 | 60.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 19 | 105 | $9,450 | $5,933 | 62.8% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 22 | 121 | $8,470 | $5,299 | 62.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $6,060 | $3,475 | 57.3% |
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2021 | 15 | 57 | $3,135 | $2,030 | 64.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $2,880 | $1,510 | 52.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 26 | $2,150 | $1,290 | 60.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2021 | 13 | 13 | $390.00 | $226.98 | 58.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 67 | $10,625 | $5,703 | 53.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 49 | $6,125 | $2,744 | 44.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $1,560 | $806.06 | 51.7% |
About Dr. Suzanne Mackey, M.D
Dr. Suzanne Mackey, M.D is a Obesity Medicine healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972574523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Mackey, M.D has received a total of $75,178 in payments from pharmaceutical and medical device companies, with $25,576 received in 2024. These payments were reported across 290 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,422).
As a Medicare-enrolled provider, Mackey has provided services to 517 Medicare beneficiaries, totaling 1,538 services with total Medicare billing of $94,882. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Obesity Medicine
- Other Specialties Gynecology, Obesity Medicine
- Location Voorhees, NJ
- Active Since 01/31/2006
- Last Updated 02/19/2019
- Taxonomy Code 207VB0002X
- Entity Type Individual
- NPI Number 1972574523
Products in Payments
- Wegovy (Drug) $34,082
- Saxenda (Drug) $31,158
- Ozempic (Drug) $1,759
- CONTRAVE (Drug) $544.26
- FREESTYLE LIBRE 3 (Device) $168.28
- Rybelsus (Drug) $109.83
- NASCOBAL (Drug) $105.01
- ZEPBOUND (Drug) $101.61
- RELTONE 200 MG (Drug) $85.20
- Imcivree (Drug) $66.26
- Victoza (Drug) $52.74
- TRULICITY (Drug) $51.08
- Belviq (Drug) $48.28
- RYBELSUS (Drug) $36.32
- FREESTYLE LIBRE (Device) $31.42
- MOUNJARO (Drug) $30.32
- QSYMIA (Drug) $29.36
- IMCIVREE (Drug) $27.16
- Tresiba (Drug) $25.45
- FREESTYLE LIBRE 2 (Device) $19.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.